Plasma Surgery Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

The global Plasma Surgery Market, which boasted a revenue of approximately US$ 72 million in 2024, is poised for substantial growth, with projections estimating a valuation of around US$ 111 million by the end of 2031. The market's growth is being fueled by a surge in the utilization of Platelet Rich Plasma (PRP) in cosmetic surgery and wound healing procedures.

Increasing Use of PRP in Cosmetic and Wound Healing Surgery

One of the key drivers of the Plasma Surgery Market is the non-invasive skin tightening technique known as plasma fibroblast, which is particularly effective for nose contouring, pore reduction, skin tone enhancement, and skin shaping. According to the American Society of Plastic Surgeons, nose reshaping was the most prevalent cosmetic procedure for the face in 2020, with 352,555 patients undergoing the treatment.

The regenerative potential of PRP has been extensively studied and applied in various aspects of plastic surgery. In 2020, over 231,140 aesthetic surgeries were performed using PRP, further boosting the demand for plasma surgery. Notable outcomes of plasma surgery include accelerated wound healing, bone formation in osteonecrosis of the jaw, and soft tissue repair following dental surgery.

Growth Opportunities Driven by Healthcare Spending

Rising healthcare expenditures offer significant revenue potential for hospitals and businesses. According to the Organization for Economic Cooperation and Development (OECD), global healthcare spending reached an astounding US$ 10 trillion by 2020, with healthcare expenditure outpacing GDP growth in many European nations.

Challenges in Electrosurgery and Burn Risks

However, the growth of the Plasma Surgery Market is not without challenges. Electrosurgery is associated with complications such as the risk of flammable gases, interference with pacemakers and monitors, neuromuscular stimulation leading to ventricular fibrillation, accidental burns, and infection transmission. Laparoscopic surgery using electrosurgical devices can result in injuries and damage, with unrecognized intestinal injuries and significant vascular damage being potential consequences. Burn cases and operating room mishaps have also affected the safety reputation of plasma surgery, potentially hindering market growth.

Country-wise Insights:

United States Market Boom

The United States stands out in the Plasma Surgery Market due to the increasing application of PRP-based treatments in orthopedic and cosmetic procedures. In 2020, the American Society of Plastic Surgeons reported 15.6 million cosmetic procedures performed in the U.S., with soft tissue filler, resurfacing, laser hair removal, and Botox being popular minimally invasive procedures. PRP therapy is highly sought after in the treatment of sports injuries, especially ACL injuries, driving the market's growth in the country.

United Kingdom's Lucrative Market

In the United Kingdom, the adoption of non-invasive cosmetic surgeries is on the rise, with 43% of the population considering them part of their beauty regimen. Cosmetic procedures such as breast augmentation, breast reduction, liposuction, and abdominoplasty, along with the use of PRP in conjunction with plastic surgery, are driving the market.

China's Prominence in the Market

China's Plasma Surgery Market is emerging as a prominent player, driven by the need to reduce the cancer burden and enhance oncology treatment options. The country has seen a surge in oncology-focused biotech companies and research standards. The approval of cold atmospheric plasma technology by the United States Food and Drug Administration for clinical trials has further boosted the market, as cold plasma therapies are utilized in oncological treatments.

Competitive Landscape

Key players in the Plasma Surgery Market are leveraging organic and inorganic growth strategies, including new product launches and partnerships with major players and research institutes, to gain a competitive edge. Some of the key companies in the market include,

• Plasma surgical
• Mechan Europe ltd
• Bovie medical corporation (Apyx Medical Corporation)
• Nova Plasma Ltd.
• Royal Biologics
• 4T Medical
• Dutch Ophthalmic Research Center
• Alfa Instruments

Key Segments Covered in Plasma Surgery Industry Research

By Product:

• Neutral Plasma Surgery System
• Plasma Ablation Systems
• Cold Plasma Surgical Systems

By Application:

• Ablation
• Resection
• Dissection

End User

• Speciality Clinics
• Ambulatory Surgical Centers
• Hospitals

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

This product will be delivered within 1-3 business days.